Health TidingsApotex Delivers First Canadian‑Made Generic Ozempic Equivalent to Market Apotex Delivers First Canadian‑Made Generic Ozempic Equivalent to Market Read Post »
Health TidingsNeurocrine’s CRENESSITY Delivers Two-Year Hormone Control in Pediatric CA... Neurocrine’s CRENESSITY Delivers Two-Year Hormone Control in Pediatric CA... Read Post »
Health TidingsIncyte Secures FDA Nod for Jakafi XR Extended-Release Tablets Incyte Secures FDA Nod for Jakafi XR Extended-Release Tablets Read Post »
Health TidingsVanda Launches NEREUS™ (Tradipitant) in the U.S. for Motion Sickness Rela... Vanda Launches NEREUS™ (Tradipitant) in the U.S. for Motion Sickness Rela... Read Post »
ManufacturingAREXVY Gains FDA Approval for Ready-to-Use Vial and Prefilled Syringe AREXVY Gains FDA Approval for Ready-to-Use Vial and Prefilled Syringe Read Post »
New Drug ApprovalFDA Clears VEPPANU, First PROTAC Therapy, for Advanced Breast Cancer FDA Clears VEPPANU, First PROTAC Therapy, for Advanced Breast Cancer Read Post »
Health TidingsRevolution Medicines Secures FDA Expanded Access for Daraxonrasib in PDAC Revolution Medicines Secures FDA Expanded Access for Daraxonrasib in PDAC Read Post »
New Drug ApprovalMHRA Clears Linerixibat (Lynavoy) for PBC-Related Itch in Adults MHRA Clears Linerixibat (Lynavoy) for PBC-Related Itch in Adults Read Post »
New Drug ApprovalJohnson & Johnson Secures FDA Nod for STELARA in Pediatric Crohn’s Johnson & Johnson Secures FDA Nod for STELARA in Pediatric Crohn’s Read Post »
Drugs Safety AlertMHRA Sets 5-Day Limit on OTC Nasal Decongestant Sprays MHRA Sets 5-Day Limit on OTC Nasal Decongestant Sprays Read Post »
New Drug ApprovalRhythm Wins EU Approval for IMCIVREE in Acquired Hypothalamic Obesity Rhythm Wins EU Approval for IMCIVREE in Acquired Hypothalamic Obesity Read Post »
New Drug ApprovalArrowhead Breaks the Triglyceride Barrier with REDEMPLO Approval in Austral... Arrowhead Breaks the Triglyceride Barrier with REDEMPLO Approval in Austral... Read Post »
Clinical TrialsCorcept Drives Survival Gain in ALS Despite Missing Primary Endpoint Corcept Drives Survival Gain in ALS Despite Missing Primary Endpoint Read Post »
Health Tidings Mergers & AcquisitionsUCB Taps IMIDomics to Power Its Precision Medicine Engine UCB Taps IMIDomics to Power Its Precision Medicine Engine Read Post »
Health TidingsFDA Panel Votes Against AstraZeneca’s Camizestrant Combo FDA Panel Votes Against AstraZeneca’s Camizestrant Combo Read Post »
Regulatory & Health PolicyFDA Acts to Restrict Compounding of Popular GLP-1 Therapies from Bulk Subst... FDA Acts to Restrict Compounding of Popular GLP-1 Therapies from Bulk Subst... Read Post »
Health TidingsAstraZeneca Reports Positive FDA Panel Vote for Truqap Combination AstraZeneca Reports Positive FDA Panel Vote for Truqap Combination Read Post »
New Drug ApprovalAxsome Wins FDA Decision for Auvelity in Alzheimer’s Agitation Axsome Wins FDA Decision for Auvelity in Alzheimer’s Agitation Read Post »
Health TidingsJohnson & Johnson Discontinues CD20 and CD19–CD20 CAR-Tv Programs in ... Johnson & Johnson Discontinues CD20 and CD19–CD20 CAR-Tv Programs in ... Read Post »
